USMLE Step 3
The United States Medical Licensing Examination Step 3 (USMLE Step 3) is the final examination in the USMLE sequence, designed to evaluate a physician's ability to apply medical knowledge and understanding of biomedical and clinical sciences essential for unsupervised practice of medicine, with a particular emphasis on patient management in ambulatory settings and the delivery of general medical care.[1] It serves as a key component for obtaining a medical license in the United States, confirming readiness for independent patient care responsibilities.[1] Administered primarily to graduates of accredited medical schools who have passed USMLE Step 1 and Step 2 Clinical Knowledge (CK), Step 3 eligibility also requires international medical graduates to hold valid Educational Commission for Foreign Medical Graduates (ECFMG) certification; as of July 1, 2025, graduates of Canadian medical schools are classified as IMGs and require ECFMG certification.[2] [3] [4] The USMLE program recommends that applicants have completed, or be near completion of, at least one year of accredited postgraduate training, such as an internship, to ensure preparedness for the exam's focus on independent decision-making.[2] Graduates of U.S. medical schools and pre-July 1, 2025 Canadian medical school graduates (MD or DO degrees from LCME- or COCA-accredited institutions), as well as international medical graduates with ECFMG certification, apply through the Federation of State Medical Boards (FSMB); as of 2025, Step 3 services are transitioning to the National Board of Medical Examiners (NBME).[5] [6] The exam is a two-day, computer-based test delivered at Prometric testing centers, spanning approximately 16 hours including breaks.[1] Day 1, titled Foundations of Independent Practice (FIP), consists of 232 multiple-choice questions (MCQs) divided into six 60-minute blocks of 38-39 items each, covering foundational topics such as biostatistics (11-13% of content), epidemiology, ethics, patient safety, and systems-based knowledge like cardiovascular (9-11%) and pulmonary diseases.[1] [7] Day 2, Advanced Clinical Medicine (ACM), includes 180 MCQs in six 45-minute blocks of 30 items each, plus 13 computer-based case simulations (CCS) that require interactive management of virtual patients over 10-20 minutes per case, emphasizing clinical decision-making across ambulatory, inpatient, and emergency settings.[1] [7] MCQ formats incorporate patient scenarios, pharmaceutical advertisements, and abstracts to test application of knowledge in diverse clinical encounters, including initial workups, continuing care, and urgent interventions.[8] Step 3 content is organized by physician tasks—such as laboratory/diagnostic studies (9-12%), diagnosis (33-36%), and management (32-35%)—and reflects competencies needed for general, undifferentiated physicians treating diverse patient populations.[7] Scores are reported on a three-digit scale, with a passing threshold typically requiring approximately 60% correct answers, resulting in a minimum passing score of 200; examinees receive pass/fail outcomes overall, but detailed score reports include performance profiles by content area.[9] [10] Results are generally available within three to four weeks, and passing Step 3, along with the prior steps, fulfills a major requirement for state medical licensure across the U.S.[9]Overview
Purpose and Scope
The United States Medical Licensing Examination (USMLE) Step 3 serves as the final assessment in the USMLE sequence, designed to evaluate the knowledge and skills of physicians assuming independent responsibility for delivering general medical care to patients.[1] It emphasizes the application of biomedical and clinical sciences in patient management, particularly in unsupervised practice as a generalist physician.[7] Unlike Steps 1 and 2, which focus on foundational scientific principles and diagnostic reasoning, Step 3 uniquely tests the practical application of medical knowledge across diverse clinical scenarios, such as office visits, hospital admissions, and emergency interventions, rather than isolated basic science or diagnostic elements alone.[1] The scope of Step 3 encompasses three primary clinical encounter frames that reflect the breadth of independent practice. Initial workup involves the first-time assessment and management of clinical problems, including history-taking, physical examinations, and diagnostic studies, typically in ambulatory settings for new patients or emerging issues.[7] Continuing care addresses the ongoing management of established conditions, such as prognosis determination, health maintenance, and therapeutic adjustments, often for patients under long-term physician oversight.[7] Urgent interventions focus on rapid evaluation and treatment of life-threatening or organ-compromising emergencies, requiring prompt decision-making in high-stakes situations.[7] These elements are assessed within various sites of care to simulate real-world generalist responsibilities, including ambulatory environments (e.g., physician offices or home care), inpatient facilities (e.g., hospitals or intensive care units), and emergency departments.[7] As the culminating step in the USMLE sequence, it builds on prior examinations to confirm readiness for full licensure and unsupervised practice.[1]Role in Licensure
The United States Medical Licensing Examination (USMLE) Step 3 serves as the final component in the USMLE sequence required for obtaining full, unrestricted medical licensure in all 50 states and the District of Columbia.[11] Successful completion of Step 3, along with Steps 1 and 2, is mandated by every state medical board as proof of the competency needed for independent medical practice, with no federal oversight dictating licensure standards.[11] Typically, candidates take Step 3 after at least one year of accredited postgraduate training (residency), as this timing aligns with the exam's focus on applying knowledge in unsupervised settings following initial supervised experience.[2] State variations exist in the precise timing and additional stipulations; for instance, while most states require Step 3 for initial licensure post-residency, a few allow limited licenses during training without it, and others impose it as a condition for license renewal or expansion of practice scope.[12] For international medical graduates (IMGs), passing Step 3 is integrated with obtaining Educational Commission for Foreign Medical Graduates (ECFMG) certification—achieved via Steps 1 and 2—and completing U.S. residency training, enabling eligibility for full licensure on par with U.S. graduates.[13] IMGs must hold a valid ECFMG certificate to apply for Step 3.[4] State requirements for postgraduate training vary, typically 1-3 years or equivalent for both U.S./Canadian graduates and IMGs via traditional paths, but as of 2025, several states offer alternative pathways allowing experienced IMGs to obtain unrestricted licenses after passing Step 3 and meeting other assessments, without additional U.S. training.[12][14] State-specific rules also apply to attempt limits (typically three to six) and time frames (often seven to ten years to complete all steps).[12] Unlike Steps 1 and 2, which are generally completed during medical school to assess foundational knowledge and clinical skills, Step 3 is uniquely administered during or after the first year of residency, marking the transition to unsupervised patient care.[15]History and Development
Origins
The United States Medical Licensing Examination (USMLE) Step 3 was developed in the late 1980s as part of the broader USMLE program, which was jointly established by the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME) to create a unified pathway for medical licensure in the United States.[16] Introduced between 1992 and 1994, Step 3 specifically replaced the fragmented systems of the NBME Part III examination and the FSMB's Federation Licensing Examination (FLEX) Component 2, aiming to streamline the assessment process for physicians entering unsupervised practice.[16][17] This hybrid approach combined elements from both prior exams to form a single, standardized evaluation, marking the culmination of efforts to consolidate disparate licensure requirements across state medical boards. The initial goal of Step 3 was to assess the clinical judgment and decision-making abilities essential for independent medical practice, building upon the foundational basic sciences covered in Step 1 and the clinical knowledge evaluated in Step 2.[7] By focusing on the application of biomedical and clinical sciences in real-world scenarios, it emphasized competencies needed for safe and effective patient care, including principles that would later align with evidence-based medicine.[16] This design reflected the progression of medical training toward unsupervised responsibility, ensuring that candidates could manage patient care without direct supervision.[7] In its early format, Step 3 incorporated multiple-choice questions to test diagnostic and management skills, along with interactive elements to simulate clinical decision-making, and was first administered in June 1994.[18] A key milestone came in 1999 with the integration of full computer-based testing, which introduced computer-based case simulations (CCS) to more effectively evaluate patient management in dynamic scenarios.[16] Over time, this foundation evolved into the current two-day structure, but the core emphasis on clinical judgment for independent practice has remained central since inception.[16]Major Changes
The United States Medical Licensing Examination (USMLE) Step 3 has undergone several significant modifications since its inception to better align with evolving standards in medical practice and physician competency assessment. One pivotal change occurred in November 1999, when Step 3 transitioned to a fully computer-administered format that incorporated Computer-based Case Simulations (CCS) as a core component on the second day of the exam. These interactive simulations were designed to evaluate examinees' ability to manage patient cases in real-time, simulating clinical decision-making under dynamic conditions, thereby enhancing the assessment of practical skills beyond traditional multiple-choice questions. In 2014, Step 3 was restructured to divide the exam into two distinct days: Day 1, Foundations of Independent Practice (FIP), focusing on foundational sciences such as biostatistics, epidemiology, ethics, and systems-based practice; and Day 2, Advanced Clinical Medicine (ACM), emphasizing clinical management through multiple-choice questions and CCS cases. This change, effective for exams beginning November 3, 2014, aimed to better assess the progression from foundational knowledge to advanced patient care skills.[19] In the 2010s, the exam's content outline was refined to place greater emphasis on foundational sciences applied to patient care, including biostatistics, epidemiology, and population health, which now constitute 11-13% of the multiple-choice questions. This shift aimed to strengthen evaluation of evidence-based medicine and public health competencies essential for independent practice. Additionally, the outline incorporated explicit focus on physician tasks such as patient communication, professionalism, and systems-based practice, reflecting broader accreditation standards from organizations like the Accreditation Council for Graduate Medical Education (ACGME).[7][7] Most recently, effective January 1, 2024, the minimum passing score for Step 3 was raised from 198 to 200 on the three-digit reporting scale, a decision made by the USMLE Management Committee following periodic review of examinee performance data to maintain rigorous competency thresholds amid rising applicant preparation levels. This adjustment did not alter the overall 300-point scale or scoring methodology but underscores ongoing efforts to ensure Step 3 remains a robust measure of readiness for unsupervised practice.[20]Eligibility and Registration
Requirements
To be eligible to take the USMLE Step 3, candidates must first pass both the USMLE Step 1 and Step 2 Clinical Knowledge (CK) examinations, with no specific sequence required between those two steps, though Step 3 may only be attempted after both have been successfully completed.[3] This prerequisite ensures that examinees have demonstrated foundational knowledge and clinical skills prior to advancing to the assessment of independent practice capabilities.[2] Candidates must hold a Doctor of Medicine (MD) or Doctor of Osteopathic Medicine (DO) degree from a medical school accredited by the Liaison Committee on Medical Education (LCME) or the Commission on Osteopathic College Accreditation (COCA), or an equivalent degree from an international medical school listed in the World Directory of Medical Schools that meets Educational Commission for Foreign Medical Graduates (ECFMG) eligibility criteria. For graduates of Canadian medical schools on or after July 1, 2025, ECFMG Certification is required.[2] For international medical graduates (IMGs), including U.S. citizens who attended non-accredited schools abroad, ECFMG Certification is mandatory, which itself requires passing Step 1 and Step 2 CK along with verification of medical education credentials.[13] The USMLE program recommends that applicants have completed, or be near completion of, at least one year of postgraduate training in an Accreditation Council for Graduate Medical Education (ACGME)-accredited U.S. program by the time of application, though this is a guideline rather than a strict barrier to sitting for the exam; however, most state medical licensing boards require this training for subsequent licensure.[2] There are no age restrictions or overall time limits imposed by the USMLE program for eligibility to take Step 3, provided the above prerequisites are met.[2] Applications are processed through the Federation of State Medical Boards (FSMB) for most U.S. and international graduates, though candidates seeking licensure in certain states must apply directly via that state's medical board.[21] Required documentation includes official medical school transcripts verifying degree conferral, proof of passing Step 1 and Step 2 CK scores, ECFMG Certification (if applicable), and verification of any postgraduate training.[22] The application fee is $935 as of 2025, payable via credit card, with additional fees for rescheduling or extending eligibility periods.[21]Application Process
The application for USMLE Step 3 is handled exclusively through the Federation of State Medical Boards (FSMB) for both graduates of U.S. and Canadian medical schools (MD or DO degrees from LCME- or COCA-accredited institutions) and international medical graduates (IMGs). Graduates of Canadian medical schools on or after July 1, 2025, must hold a valid ECFMG Certificate, similar to IMGs. IMGs must hold a valid, unexpired ECFMG Certificate as a prerequisite for eligibility before applying via FSMB. There is no direct application option through the National Board of Medical Examiners (NBME).[4][22][13] Applicants begin by creating an account on the FSMB's USMLE portal at usmle.fsmb.org and completing the online application, which requires confirming eligibility (such as passing Step 1 and Step 2 CK, as detailed in the Requirements section) and providing necessary documentation like degree verification. The non-refundable application fee for 2025 is $935, payable via American Express, MasterCard, or Visa. Upon submission, FSMB processes the application in approximately 7-10 business days to issue a scheduling permit via email, though this may extend to 12 weeks for recent graduates awaiting medical school degree verification.[22][23] With the scheduling permit in hand, applicants must create an account on the Prometric website to view available dates and select a testing center from the network of Prometric facilities across the United States and its territories. Step 3 is offered year-round except during the first 14 days of January and major local holidays, with appointments bookable up to six months in advance on a first-come, first-served basis to ensure availability at preferred locations.[5][24][23] Rescheduling within the three-month eligibility period is allowed by contacting Prometric directly, with no fee applied if the change occurs 46 or more days before the original appointment date. Fees are charged for later changes: $35 for rescheduling 31-45 days prior, escalating to higher amounts (up to $275 in some cases) for adjustments 5-30 days prior, and possible restrictions or full forfeiture if within 5 days. Cancellations follow a similar tiered fee structure based on timing.[25][5] For applicants with disabilities or medical conditions requiring accommodations, requests are submitted to the NBME's Disability Services using dedicated forms such as the Accommodations Request Form, supported by a personal statement and documentation from a qualified professional (e.g., physician or psychologist). Examples include extended testing time, additional unscheduled breaks, magnification software for visual impairments, or adjustments for conditions like lactation needs; approvals are case-specific and should be requested concurrently with or soon after application submission to allow processing time.[26] In 2025, the FSMB portal supports streamlined identity verification and application tracking for faster overall processing, while testing remains restricted to Prometric centers in the United States and its territories, with no international options available.[22][5]Examination Format
Day 1: Foundations of Independent Practice
Day 1 of the USMLE Step 3 examination, known as the Foundations of Independent Practice (FIP), assesses foundational knowledge and skills essential for unsupervised medical practice through a multiple-choice question (MCQ) format.[1] This day integrates basic medical sciences, clinical knowledge, and applied principles to evaluate a candidate's ability to apply concepts in patient care scenarios, including diagnosis, management, and preventive health strategies.[7] Unlike interactive simulations, all items are presented as traditional MCQs without real-time decision-making components.[1] The testing session lasts approximately 7 hours, comprising 6 blocks of MCQs with 60 minutes allotted per block.[1] Each block contains 38 or 39 items, resulting in a total of 232 multiple-choice questions across the day.[1] An optional 5-minute tutorial precedes the first block to familiarize candidates with the testing interface.[1] Breaks include 5 minutes between blocks and a designated 45-minute lunch period, with additional time potentially available if blocks or the tutorial conclude early.[1] Question formats primarily consist of single-best-answer MCQs, often presented as vignettes describing clinical scenarios, which may incorporate pictorials, audio, or charts for realism.[8] Specialized formats include pharmaceutical advertisements, where candidates interpret drug promotion materials in the context of clinical decision-making, and scientific abstracts, requiring analysis of research summaries for application to patient care.[8] Questions may appear as standalone items or in sequential/non-sequential sets of 2-3 related to a shared scenario.[8] Content emphasizes continuing care, with topics such as biostatistics and epidemiology comprising 11-13% of the items to test interpretation of medical literature and population health principles.[7] Overall, the MCQs draw from an integrated outline covering organ systems and physician tasks like history-taking, physical examination, and diagnostic studies.[7]Day 2: Advanced Clinical Medicine
Day 2 of the USMLE Step 3, known as Advanced Clinical Medicine, assesses examinees' ability to apply medical knowledge in patient management scenarios, emphasizing decision-making in evolving clinical situations. This day totals approximately 9 hours, beginning with 180 multiple-choice questions (MCQs) divided into 6 blocks of 30 items each, with 45 minutes allotted per block.[1] Following the MCQs is a 7-minute tutorial on the Computer-based Case Simulations (CCS) software, then 13 case simulations, each allocated a maximum of 10 or 20 minutes of real time.[1] Unlike Day 1's focus on foundational knowledge through MCQs, Day 2 integrates interactive simulations to evaluate practical application.[1] The CCS portion utilizes Primum software to create dynamic, real-time simulations of patient encounters, where examinees must diagnose, order diagnostic tests, initiate treatments, and monitor outcomes over simulated time.[27] Cases advance through actions such as entering free-text orders and using a clock to progress the scenario, reflecting settings like emergency departments or inpatient units.[27] Scoring for CCS is determined by algorithms that compare examinee actions to expert standards, awarding credit for appropriate, timely interventions while deducting for delays, omissions, or errors, with emphasis on efficiency and patient outcomes.[27] The content prioritizes urgent interventions and inpatient management across diverse patient populations, including pediatric, adult, and geriatric cases involving acute and chronic conditions.[1] Examinees encounter scenarios requiring therapeutic decisions, prognostic assessments, and health maintenance strategies.[1] Break scheduling includes a minimum of 45 minutes total optional break time, plus a designated 45-minute lunch break, with 10 minutes potentially available between CCS cases depending on pacing.[1] The MCQ blocks on this day similarly test advanced clinical reasoning, often building on management themes from the simulations.Content Outline
Organ Systems and Topics
The USMLE Step 3 examination evaluates a candidate's ability to apply medical knowledge and clinical skills across various organ systems and interdisciplinary topics, reflecting the responsibilities of an independent physician in diverse care settings. The content is organized into specific organ systems, multisystem processes, and cross-cutting disciplines, with approximate distributions for multiple-choice questions (MCQs) outlined in official specifications. These categories ensure comprehensive coverage of foundational science principles integrated with clinical management, spanning conditions encountered in ambulatory, inpatient, and emergency environments. The content outline was last updated in January 2024, incorporating a new "Human Development" category and redistributing topics from "General Principles of Foundational Science" into organ systems without altering overall proportions.[28][7] The organ systems and related topics form the core of the exam's subject matter, with distributions designed to emphasize high-prevalence and high-impact diseases. For instance, cardiovascular and biostatistics/epidemiology topics receive significant weight due to their relevance in preventive care and population health management. The following table summarizes the approximate percentage ranges for MCQs across these categories:| Category | Approximate % of MCQs |
|---|---|
| Biostatistics & Epidemiology/Population Health & Interpretation of Medical Literature | 11–13% |
| Cardiovascular System | 9–11% |
| Nervous System & Special Senses | 8–10% |
| Respiratory System | 8–10% |
| Pregnancy/Childbirth & Female Reproductive System & Breast | 7–9% |
| Social Sciences: Communication Skills/Ethics/Patient Safety | 7–9% |
| Immune System, Blood & Lymphoreticular System, Multisystem Processes/Disorders | 6–8% |
| Gastrointestinal System | 6–8% |
| Behavioral Health | 4–6% |
| Skin & Subcutaneous Tissue | 4–6% |
| Renal/Urinary & Male Reproductive Systems | 4–6% |
| Endocrine System | 5–7% |
| Musculoskeletal System | 5–7% |
| Human Development | 1–3% |
Physician Tasks and Competencies
The physician tasks and competencies assessed on USMLE Step 3 align with the Accreditation Council for Graduate Medical Education (ACGME) core competencies, emphasizing the application of medical knowledge to patient care in unsupervised practice.[30] These tasks evaluate a candidate's ability to integrate foundational science, diagnostic reasoning, management strategies, and professional behaviors across diverse clinical scenarios.[7] The examination tests these elements through multiple-choice questions (MCQs) and computer-based case simulations (CCS), with a focus on real-world decision-making in ambulatory, inpatient, and emergency settings.[7] In the MCQ portion, which comprises approximately 80% of Day 1 and all of Day 2, the distribution of physician tasks is as follows:| Task Category | Percentage of MCQs | Key Subcomponents |
|---|---|---|
| Patient Care: Diagnosis | 33–36% | History/physical exam (5–9%), laboratory/diagnostic studies (9–12%), diagnosis (6–10%), prognosis/outcome (8–11%) |
| Patient Care: Management | 32–35% | Health maintenance/disease prevention (6–11%), pharmacotherapy (9–13%), clinical interventions (5–9%), mixed management (6–11%) |
| Medical Knowledge: Applying Foundational Science Concepts | 11–12% | Integration of basic sciences (e.g., pharmacology, pathophysiology) to clinical problems |
| Practice-based Learning and Improvement | 11–13% | Evidence-based medicine, biostatistics, self-assessment, and quality improvement |
| Communication/Professionalism/Systems-based Practice and Patient Safety | 7–9% | Ethical decision-making, patient communication, systems navigation, and error prevention |
Scoring and Results
Scoring Methodology
The USMLE Step 3 examination yields a single overall score reported on a three-digit scale ranging from 1 to 300, derived from performance across both days of testing using Item Response Theory (IRT) to equate scores and adjust for variations in test form difficulty.[31] This methodology ensures comparability of scores across different administrations by scaling examinee ability relative to item characteristics.[9] The overall score combines performance on Day 1 multiple-choice questions, Day 2 multiple-choice questions, and the computer-based case simulations (CCS) on Day 2, with the CCS portion weighted proportionally to its time allocation in the exam and no greater than that proportion.[9] No raw scores or number of correct answers are reported to examinees.[9] The standard error of measurement (SEM) for Step 3 scores is approximately 5 points, representing the imprecision in score estimates and indicating that about two-thirds of a examinee's true scores would fall within plus or minus one SEM of the reported score.[31] While there are no official subscores, the score report includes diagnostic profiles showing performance ranges across major organ systems, disciplines, and physician tasks/competencies, allowing examinees to identify relative strengths and weaknesses for self-assessment.[32] Score reports provide a pass/fail outcome along with the numeric score for those who pass, released 2 to 4 weeks (up to 8 weeks maximum) after completion of Day 2 and accessible via email notification and the portal of the registering entity, such as the Federation of State Medical Boards (FSMB).[9] The passing standard is determined through periodic reviews using criterion-referenced methods like the Angoff procedure to establish the minimum proficiency level required for unsupervised practice.[9] Step 3 scores remain valid indefinitely for purposes of medical licensure, though state medical boards may impose time limits on completing the full sequence of USMLE Steps 1, 2, and 3.[3]Pass/Fail Determination
The passing score for USMLE Step 3 is 200 on the three-digit scale, effective for examinations taken on or after January 1, 2024; this represents an increase from the previous standard of 198.[20] Achieving this threshold typically requires examinees to answer approximately 60% of the multiple-choice questions correctly, with scores adjusted for variations in test form difficulty.[9] This standard remained unchanged in 2025.[10] Examinees receive a three-digit score along with a pass or fail outcome on their official score report, regardless of whether they pass or fail; a score of 200 or higher results in a pass, while scores below 200 result in a fail.[3] For those who fail, the score report provides diagnostic information on performance across content areas and physician tasks to guide remediation, but the failing outcome must be addressed through retesting to meet licensure requirements, as passing Step 3 is mandatory for obtaining an unrestricted medical license in all U.S. states and territories.[9][15] Retesting is permitted after a minimum waiting period of 60 days, subject to broader USMLE attempt limits.[33] The USMLE program allows up to four lifetime attempts per Step, including incomplete attempts; examinees may take the examination no more than three times within any 12-month period, with any fourth attempt required to occur at least 12 months after the first attempt and 6 months after the most recent attempt on that Step.[2] After four unsuccessful attempts, individuals become ineligible to apply for any USMLE Step, though state medical boards may impose additional restrictions on the number of failures permitted for licensure.[34] For multiple attempts, the highest passing score is reported on official transcripts sent to state boards and other entities, while all attempts (passed or failed) are documented.[35] In borderline cases near the passing threshold, performance on the Computer-based Case Simulations (CCS) portion carries significant weight, as it contributes proportionally to the overall score and can determine the final pass/fail outcome.[9]Performance Data
Pass Rates
The first-time pass rate for USMLE Step 3 in 2024 was 97% for graduates of U.S./Canadian MD-granting schools, 93% for DO-granting schools, and 89% for international medical graduates (IMGs), resulting in an overall first-time pass rate of approximately 95%.[36] Repeat takers in 2024 achieved pass rates of 73% for U.S./Canadian MD graduates, 60% for DO graduates, and 64% for IMGs.[36] Historical first-time pass rates have remained stable and high since 2013, typically ranging from 94% to 98% overall, with U.S./Canadian MD graduates consistently at 97-98% and IMGs at 86-92%. For instance, in 2020 amid pandemic-related disruptions, rates were 98% for U.S./Canadian MDs, 91% for DOs, and 90% for IMGs, showing minimal impact compared to earlier steps.[36] Repeat taker success has hovered between 60% and 77% across groups, with U.S./Canadian MDs generally outperforming others at 70-77%.[36][37]| Year | U.S./Canadian MD (First-Time) | DO (First-Time) | IMG (First-Time) | Overall Repeat Takers (Approx.) |
|---|---|---|---|---|
| 2013 | 97% | 96% | 87% | 64-78% |
| 2018 | 98% | 96% | 90% | 59-73% |
| 2023 | 97% | 95% | 92% | 64-77% |
| 2024 | 97% | 93% | 89% | 60-73% |